Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 2552-55-8 Chemical Structure| 2552-55-8

Structure of Ibotenic acid
CAS No.: 2552-55-8

Chemical Structure| 2552-55-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ibotenic acid has agonist activity at both the N-methyl-D-aspartate (NMDA) and trans-ACPD or metabolotropic quisqualate (Qm) receptor sites.

Synonyms: DL-Ibotenic acid; NSC 204850; Ibotenate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ibotenic acid

CAS No. :2552-55-8
Formula : C5H6N2O4
M.W : 158.11
SMILES Code : O=C(O)C(N)C(ON1)=CC1=O
Synonyms :
DL-Ibotenic acid; NSC 204850; Ibotenate
MDL No. :MFCD00069294
InChI Key :IRJCBFDCFXCWGO-UHFFFAOYSA-N
Pubchem ID :1233

Safety of Ibotenic acid

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301
Precautionary Statements:P301+P310
Class:6.1
UN#:2811
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Primary cortical neurons 50 µM 3 and 6 hours To evaluate the effect of ibotenate on neuronal autophagy, results showed increased LC3-II expression and enhanced SQSTM1 degradation, indicating enhanced autophagic flux. Cell Death Dis. 2018 Aug 28;9(9):853
PC12 rat pheochromocytoma cells 1 mM 24 hours To investigate the effect of ibotenic acid on the viability of PC12 cells under nutrient deprivation, results showed that ibotenic acid significantly reduced cell viability. Cell Mol Life Sci. 2020 Sep;77(17):3383-3399
SH-SY5Y neuroblastoma cells 1 mM 24 hours To investigate the effect of ibotenic acid on the viability of SH-SY5Y cells under nutrient deprivation, results showed that ibotenic acid significantly reduced cell viability. Cell Mol Life Sci. 2020 Sep;77(17):3383-3399

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
CD-1 male mice Surgery mouse model Intracerebral injection into PVT region 300 nl 0.3% ibotenic acid Single injection, behavioral tests performed after 5 days of recovery After ibotenic acid-induced PVT neuronal injury, the consolation and anxious behaviors of familiar observers toward surgery mice were abolished Theranostics. 2021 Feb 6;11(8):3813-3829
Rats RMTg neuron lesion model Intracerebral injection 1% in saline, 200 nL/side Single injection To evaluate the effect of RMTg neuron lesions on sleep-wake behavior. Results showed that lesions led to decreased NREM and REM sleep and increased wakefulness. PLoS Biol. 2018 Apr 13;16(4):e2002909
Male Long-Evans rats Rat gambling task (rGT) model Bilateral injection into RAIC or CGIC regions 0.2 μl/side, 20 mg/ml Single injection, 5 min diffusion time post-injection To investigate the roles of RAIC and CGIC in rGT choice behavior. RAIC lesions resulted in a greater preference for options with higher reward frequency and lower punishment, while CGIC lesions had minimal effects on choice behavior. Neuropsychopharmacology. 2015 Nov;40(12):2832-42
Rats Lateral parabrachial nucleus (PBN) lesion model Bilateral injection 20μg/μl Single injection, observed for 24 hours To evaluate the effect of PBN lesions on Ex4-induced hypophagia. Results showed that PBN-lesioned rats did not exhibit reduced food intake after Ex4 treatment, indicating that the PBN is necessary for Ex4 effects under the tested conditions. Neuropsychopharmacology. 2015 Jul;40(8):2001-14
Sprague-Dawley rats Aβ1-40 plus ibotenic acid-induced Alzheimer's disease model Bilateral hippocampal injection 2 μL mixed Aβ1-40 and ibotenic acid solution Single injection Establish an Alzheimer's disease model for subsequent metabolomic analysis and drug evaluation J Pharm Anal. 2022 Aug;12(4):627-636
Sprague-Dawley rat pups Model of preterm excitotoxic brain injury Intracerebral injection 10 µg Single injection, evaluated at 24 h and 16 days To investigate the role of ibotenate-induced autophagy in preterm brain injury, results showed enhanced autophagy associated with neuronal death, and the autophagy inhibitor 3-MA significantly reduced long-term brain injury. Cell Death Dis. 2018 Aug 28;9(9):853
Sprague-Dawley rats Parkinson’s disease rat model Intracerebral injection 45 nM Single injection To investigate the effect of cortical lesions on striatal projection neurons and interneurons in a 6-hydroxydopamine-induced Parkinson’s disease model. Results showed that cortical lesions reversed the damage to striatal projection neurons induced by 6-hydroxydopamine and inhibited the hyperplastic reaction of interneurons. Neural Regen Res. 2016 Dec;11(12):1969-1975
Sprague-Dawley rats Parkinson's disease rat model Intracerebral injection 45 nM Single injection, observed for 4 weeks To investigate the effect of ibotenic acid-induced decortication on dopamine depletion-induced striatal neuron lesions. Results showed that decortication alleviated the damage to dendritic spines and dendrites of striatal neurons caused by dopamine depletion. Int J Mol Med. 2019 Oct;44(4):1414-1424

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00005925 Epilepsy Phase 1 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00921128 Parkinson's Disease Phase 1 Withdrawn - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

6.32mL

1.26mL

0.63mL

31.62mL

6.32mL

3.16mL

63.25mL

12.65mL

6.32mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories